期刊文献+

粒细胞集落刺激因子动员外周血干细胞富集致肺损伤1例 被引量:2

Granulocyte-colony stimulating factor related lung injury in a leukemia patient during mobilization of peripheral blood stem cells
下载PDF
导出
摘要 背景:使用粒细胞集落刺激因子动员外周血干细胞后导致急性肺损伤仅有零星报道,机制尚不清楚。目的:探讨应用重组人粒细胞集落刺激因子动员外周血干细胞富集导致肺损伤的临床表现、机制。方法:报告1例粒细胞集落刺激因子动员外周血干细胞时导致咯血和影像学肺部结节状、片状阴影,并复习相关文献。结果与结论:粒细胞集落刺激因子可能会导致肺损伤,机制可能和中性粒细胞在肺部聚集、黏附、释放炎症递质有关。 BACKGROUND:There are few studies about granulocyte-colony stimulating factor related lung injury during mobilization of peripheral blood stem cells,but the mechanism is unclear.OBJECTIVE:To explore the clinical manifestation and possible pathogenic mechanism of acute lung injury related to recombinant human granulocyte-colony stimulating factor.METHODS:We reported a case of sudden hemoptysis,scattered lung nodular shadows and patchy shadows in a leukemia patient following the administration of granulocyte-colony stimulating factor to mobilize peripheral blood stem cells,and related literatures were also reviewed.RESULTS AND CONCLUSION:Granulocyte-colony stimulating factor while mobilizing peripheral blood stem cells could induce acute lung injury,which may involve migration of neutrophils to vascular spaces,adhesion of neutrophils to endothelial cells,and potentiation of proinflammatory cytokine expression.
机构地区 解放军第
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2011年第45期8547-8550,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献21

  • 1Tigue CC, McKoy JM, Evens AM, et al. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone Marrow Transplant. 2007;40(3):185-192.
  • 2de la Rubia J, de Arriba F, Arbona C, et al. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry. Haematologica. 2008; 93(5):735-740.
  • 3Cesaro S, Marson P, Gazzola MV, et al. The use of cytokine-stimulated healthy donors in allogeneic stem cell transplantation. Haematologica. 2002;87(8 Suppl):35-41.
  • 4Michael A, Chitphakdithai P, Miller JP, et al. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood. 2009;113(15):3604-3611.
  • 5Demuynck H, Zachée P, Verhoef GE, et al. Risks of rhG-CSF treatment in drug-induced agranulocytosis. Ann Hematol. 1995; 70(3):143-147.
  • 6Arimura K, Inoue H, Kukita T, et al. Acute lung Injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone. Haematologica. 2005;90(3):27-29.
  • 7Deeren DH, Zachee P, Malbrain ML. Granulocyte colony-stimulating factor-induced capillary leak syndrome confirmed by extravascular lung water measurements. Ann Hematol. 2005;84(2):89-94.
  • 8Hasegawa Y, Ninomiya H, Kamoshita M, et al. Interstitial pneumonitis related to granulocyte colony-stimulating factor administration following chemotherapy for elderly patients with non-Hodgkin's lymphoma. Intern Med. 1997;36(5):360-364.
  • 9Katoh M, Shikoshi K, Takada M, et al. Development of interstitial pneumonitis during treatment with granulocyte colony-stimulating factor. Ann Hematol. 1993;67(4):201-202.
  • 10Niitsu N, Iki S, Muroi K, et al. Interstitial pneumonia in patients receiving granulocyte colony-stimulating factor during chemotherapy: survey in Japan 1991-96. Br J Cancer. 1997; 76(12): 1661-1666.

二级参考文献8

共引文献5

同被引文献8

  • 1Tigue C C, McKoy J M, Evens A M, et al. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project[J].Bone Marrow Transplant, 2007,40(3):185-192.
  • 2De la Rubia J, De Arfiba F, Arbona C, et al, Follow-up of healthy donors receiving granulocyte colony-stimulating factor for periph- eral blood progenitor cell mobilization and collection.Results of the Spanish Donor Registry[J]. Haematologica, 2008,93(5):735-740.
  • 3Cesaro S, Marson P, Gazzola M V, et al. The use of cytokine-stim- ulated healthy donors in allogeneic stem cell transplantation [J]. Haematologica, 2002,87(8 Suppl):35-41.
  • 4Repine J E, Beechler C J. Neutrophils and adult respiratory distress syndrome: two interlocking perspectives in 1991[J]. Am Rev Respir Dis, 1991,144(2):251-252.
  • 5L Karlin, M Darmon, G Thie' ry,et al. Respiratory status deterio- ration during G-CSF-induced neutropenia recovery[J]. Bone Marrow Transplantation,2005, 36(3):245-250.
  • 6Fu J F, Hsu C L, Shih L Y.MLL/AF10(OM-LZ)-immortalized cells expressed cytokines and induced host cell proliferation in a mouse bone marrow transplantation model[J].Int J Cancer,2010, (7) 126:1621-1629.
  • 7e lie Azoulay.Michael Darmon. Acute respiratory distress syndrome duringneutropenia recovery[J]. Critical Care,2010,14(1):114-116.
  • 8吴穗晶,杜欣,陆泽生,钟立业,龙怡.粒细胞集落刺激因子动员外周造血干细胞致急性肺损伤一例[J].临床内科杂志,2004,21(5):350-350. 被引量:3

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部